Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Enanta Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Enanta Pharmaceuticals

Enanta Pharmaceuticals

Public

US-based Enanta Pharmaceuticals develops small molecule drugs for viral infections and liver diseases.

HQ
Watertown, MA, US
Founded
1995
Overview
Compare
Fundraising
Employees
Website

Founded in Watertown, United States, Enanta Pharmaceuticals is a biotechnology company dedicated to the research, development, and creation of small molecule drugs targeting viral infections and liver diseases. The company's core mission is to discover and develop highly differentiated therapeutics through innovative chemistry, addressing areas of high unmet medical need. Enanta's product portfolio includes treatments for hepatitis C, respiratory syncytial virus (RSV), and non-alcoholic steatohepatitis (NASH), among others.

Enanta Pharmaceuticals boasts a team of some of the brightest minds in the pharma and biotech sectors. The company has garnered significant attention and investment from notable figures in the industry. Its key achievements include the successful development of several antiviral therapies that have made substantial impacts on patient care. Enanta's commitment to scientific excellence and bold innovation has positioned it as a leader in creating novel medicines, significantly impacting the treatment landscape for viral and liver diseases.

Enanta Pharmaceuticals - Similar Companies

Anthera Pharmaceuticals logo

Anthera Pharmaceuticals

anthera.com

Entrada Therapeutics logo

Entrada Therapeutics

entradatx.com

Intercept Pharmaceuticals logo

Intercept Pharmaceuticals

Theravance Biopharma logo

Theravance Biopharma

theravance.com

Atea Pharmaceuticals logo

Atea Pharmaceuticals

ateapharma.com

Gilead Sciences logo

Gilead Sciences

gilead.com

Venatorx Pharmaceuticals logo

Venatorx Pharmaceuticals

venatorx.com

Enalare Therapeutics logo

Enalare Therapeutics

enalare.com

Hepanova logo

Hepanova

hepanova.com

Antios Therapeutics logo

Antios Therapeutics

Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

ionispharma.com

Altesa logo

Altesa

altesabio.com

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Ensemble Discovery logo

Ensemble Discovery

Aptinyx logo

Aptinyx

aptinyx.com

Enanta Pharmaceuticals - Quick Facts

Who are Enanta Pharmaceuticals' competitors?

Companies similar to Enanta Pharmaceuticals include Anthera Pharmaceuticals, Entrada Therapeutics, Intercept Pharmaceuticals and Theravance Biopharma.

When was Enanta Pharmaceuticals founded?

Enanta Pharmaceuticals was founded in 1995.

Where is Enanta Pharmaceuticals' headquarters located?

Enanta Pharmaceuticals' headquarters is located in Watertown, MA, US.

When was Enanta Pharmaceuticals' last funding round?

Enanta Pharmaceuticals' most recent funding round was for $9.2M (USD) in September 2013.

How much has Enanta Pharmaceuticals raised to-date?

As of Sep 3, 2013, Enanta Pharmaceuticals has raised a total of $84.6M (USD).

How many employees does Enanta Pharmaceuticals have?

Enanta Pharmaceuticals has 160 employees as of Feb 6, 2024.

Enanta Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drugs
  • Pharmaceuticals
Tags
  • Healthtech
Unique IDs
  • ein: 043205099
  • secCik: 0001177648
  • ticker: ENTA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research